Skip to content

Insights.

 

Topic

CDMO

Subscribe
Page:
1

See for yourself.

SEKISUI has vast experience with projects from pre-clinical to commercial, including but not limited to recombinant systems such as Escherichia coli and Pichia pastoris, and associated purification and analytical technologies. Our primary expertise lies in the production of proteins; however, our capabilities are also suitable for plasmids, antibody fragments, DNA modifying enzymes, and other protein production.